local_hospital

Brigade Sapeurs-Pompiers Paris

Address
1, place Jules Renard, BP 31, cedex17, 75823 Paris, France

Brigade Sapeurs-Pompiers Paris - Emergency Cardiac Care Research

Brigade Sapeurs-Pompiers Paris (Paris Fire Brigade) operates as a specialized emergency medical research center with particular expertise in pre-hospital acute cardiac care. The center focuses on advancing emergency interventions for time-critical cardiovascular conditions, conducting clinical trials that bridge the gap between initial emergency response and definitive hospital treatment.

  • ST-segment elevation myocardial infarction (STEMI) treatment protocols
  • Pre-hospital pharmacological interventions for acute coronary syndromes
  • Emergency antiplatelet therapy and bleeding risk assessment

The center's research program emphasizes optimizing outcomes for patients experiencing acute myocardial infarction by evaluating novel therapeutic agents administered in the critical pre-hospital phase. Their trials assess both efficacy in improving 30-day clinical outcomes and safety profiles, particularly monitoring bleeding complications according to established criteria such as GUSTO and BARC classifications. This unique focus on the emergency medical services setting positions the center at the forefront of developing rapid-response cardiac interventions.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
1
IMP

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
1
Outperforms 2% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
1sponsors
Outperforms 2% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Brigade Sapeurs-Pompiers Paris

Trial Sponsor Phase Status Start Date End Date
Phase 3 Randomized, Placebo-Controlled Study on the Efficacy and Safety of Zalunfiban in Pre-Hospital ST-Elevation Myocardial Infarction PatientsCelecor Therapeutics Inc.Phase IIINot RecruitingApr 2021May 2026

IMP list

IMP Trials Status First start Last start
Zalunfiban1Unknown2021-04-222021-04-22

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.